BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Staging
45 results:

  • 1. Head-to-head Comparison of the Diagnostic Accuracy of prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial staging of Intermediate- to High-risk prostate cancer: A Systematic Review and Meta-analysis.
    Chow KM; So WZ; Lee HJ; Lee A; Yap DWT; Takwoingi Y; Tay KJ; Tuan J; Thang SP; Lam W; Yuen J; Lawrentschuk N; Hofman MS; Murphy DG; Chen K
    Eur Urol; 2023 Jul; 84(1):36-48. PubMed ID: 37032189
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Impact of prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of prostate Carcinoma Primary staging: A Retrospective Analysis at the Brazilian National Public Health System.
    da Silva ACB; de Toledo LGM; de Carvalho Fernandes R; Ziroldo AR; Sawczyn GV; Alarcon ST; Lewin F
    Ann Surg Oncol; 2023 Jul; 30(7):4541-4549. PubMed ID: 36995451
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and
    Bodar YJL; Luining WI; Keizer B; Meijer D; Vellekoop A; Schaaf M; Hendrikse NH; Van Moorselaar RJA; Oprea-Lager DE; Vis AN
    Urol Oncol; 2023 Apr; 41(4):205.e17-205.e24. PubMed ID: 36588019
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Role of
    Sopeña Sutil R; Gómez Grande A; González Díaz A; Téigel Tobar J; Cabeza Rodríguez MÁ; González Billalabeitia E; Rodríguez Antolín A
    Arch Esp Urol; 2022 Oct; 75(8):684-692. PubMed ID: 36330569
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The value of 68 Ga-PSMA-11 PET/CT in patients with prostate cancer and inconclusive standard imaging at primary staging.
    Nalliah S; Zacho HD
    Nucl Med Commun; 2022 Oct; 43(10):1092-1098. PubMed ID: 35950348
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The role of MRI in the management of a prostate cancer patient with bone and lymph nodes metastases. A case report.
    Belmonte M; Saia G; Zugni F; Alessi S; Colombo A; Summers PE; Luzzago S; Marvaso G; Musi G; De Cobelli O; Jereczek-Fossa BA; Petralia G
    Acta Biomed; 2021 Sep; 92(4):e2021214. PubMed ID: 34487080
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The prognostic value of digital rectal exam for the existence of advanced pathologic features after prostatectomy.
    Prebay ZJ; Medairos R; Doolittle J; Langenstroer P; Jacobsohn K; See WA; Johnson SC
    Prostate; 2021 Oct; 81(14):1064-1070. PubMed ID: 34297858
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Application of Diffusion Weighted Imaging in prostate cancer Bone Metastasis: Detection and Therapy Evaluation.
    Gong XQ; Tao YY; Wang R; Liu N; Huang XH; Zheng J; Yang C; Yang L; Zhang XM
    Anticancer Agents Med Chem; 2021; 21(15):1950-1956. PubMed ID: 33461473
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Whole-body magnetic resonance imaging for prostate cancer assessment: Current status and future directions.
    Van Nieuwenhove S; Van Damme J; Padhani AR; Vandecaveye V; Tombal B; Wuts J; Pasoglou V; Lecouvet FE
    J Magn Reson Imaging; 2022 Mar; 55(3):653-680. PubMed ID: 33382151
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study.
    Donswijk ML; van Leeuwen PJ; Vegt E; Cheung Z; Heijmink SWTPJ; van der Poel HG; Stokkel MPM
    BMC Cancer; 2020 Aug; 20(1):723. PubMed ID: 32758168
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A Prospective Comparison of
    Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
    Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Do patients who undergo multiparametric MRI for prostate cancer benefit from additional staging imaging? Results from a statewide collaborative.
    Eyrich NW; Tosoian JJ; Drobish J; Montie JE; Qi J; Kim T; Noyes SL; Moriarity AK; Lane BR;
    Urol Oncol; 2020 Jul; 38(7):636.e13-636.e19. PubMed ID: 32067844
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Whole-body MRI: a powerful alternative to bone scan for bone marrow staging without radiation and gadolinium enhancer.
    Papageorgiou I; Dvorak J; Cosma I; Pfeil A; Teichgraeber U; Malich A
    Clin Transl Oncol; 2020 Aug; 22(8):1321-1328. PubMed ID: 31858434
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Transitioning to whole-body SPECT/CT in prostate cancer staging: a new concept for a better imaging workflow.
    Weissinger M; Kupferschläger J; La Fougère C; Dittmann H; Fiz F
    Nuklearmedizin; 2019 Dec; 58(6):451-459. PubMed ID: 31711243
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Treatment outcomes of prostate cancer patients with Gleason score 8-10 treated with definitive radiotherapy : TROD 09-001 multi-institutional study.
    Ozyigit G; Onal C; Igdem S; Alicikus ZA; Iribas A; Akin M; Yalman D; Cetin I; Aksu MG; Atalar B; Dincbas F; Hurmuz P; Guler OC; Aydin B; Sert F; Yildirim C; Gorken IB; Agaoglu FY; Korcum AF; Yuce D; Ozkok S; Darendeliler E; Akyol F
    Strahlenther Onkol; 2019 Oct; 195(10):882-893. PubMed ID: 31143994
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MRI-Based Radiomics Signature for the Preoperative Prediction of Extracapsular Extension of prostate cancer.
    Ma S; Xie H; Wang H; Han C; Yang J; Lin Z; Li Y; He Q; Wang R; Cui Y; Zhang X; Wang X
    J Magn Reson Imaging; 2019 Dec; 50(6):1914-1925. PubMed ID: 31062459
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A Review of prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in Renal Cell Carcinoma (RCC).
    Ahn T; Roberts MJ; Abduljabar A; Joshi A; Perera M; Rhee H; Wood S; Vela I
    Mol Imaging Biol; 2019 Oct; 21(5):799-807. PubMed ID: 30617728
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.
    Johnston EW; Latifoltojar A; Sidhu HS; Ramachandran N; Sokolska M; Bainbridge A; Moore C; Ahmed HU; Punwani S
    Eur Radiol; 2019 Jun; 29(6):3159-3169. PubMed ID: 30519933
    [TBL] [Abstract] [Full Text] [Related]  

  • 19.
    Lengana T; Lawal IO; Boshomane TG; Popoola GO; Mokoala KMG; Moshokoa E; Maes A; Mokgoro NP; Van de Wiele C; Vorster M; Sathekge MM
    Clin Genitourin Cancer; 2018 Oct; 16(5):392-401. PubMed ID: 30120038
    [TBL] [Abstract] [Full Text] [Related]  

  • 20.
    Wondergem M; van der Zant FM; Knol RJJ; Burgers AMG; Bos SD; de Jong IJ; Pruim J
    World J Urol; 2018 Jan; 36(1):27-34. PubMed ID: 29043431
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.